knowledge -WSS

knowledge

author：hotspot 2025-09-27 23:02:04 - browse：45191

Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble — coverage from STAT — Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble. Adobe

An early-stage clinical trial of a radiopharmaceutical drug developed by Johnson & Johnson showed some signs of efficacy in prostate cancer patients, newly released data show, but four participants in the trial died.

The drug, JNJ-6420, is designed to treat metastatic castration-resistant prostate cancer by delivering radioactive isotopes directly to cancer cells. Interest in such radiopharmaceuticals has skyrocketed following the approval of Pluvicto, which also treats prostate cancer.

In the Phase 1 data reported ahead of the American Society of Clinical Oncology meeting next week, 18% of participants on a mid-level dose of Johnson & Johnson’s treatment had a complete or partial response. For comparison, approximately 29.8% of the subjects in a Phase 3 trial of Pluvicto responded to the treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： CDC: Cases of alpha

WSS

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Ending health disparities requires full federal government, panel says

Timeline: Special counsel's probe into Trump's handling of classified documents

Paxlovid rebound happens. Why and to whom are still a mystery

St. Louis police protesters begin picking up checks in $4.9 million settlement

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

leisure time

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Trump allegedly attempted to have surveillance video deleted: Special Counsel

In Memoriam: Notable people who died in 2023

Flash flood warnings continue for parts of Missouri, Illinois

Hepatitis C has a cure — but many Americans still lack access to it

Sweden knocks USA out of World Cup in penalty kicks

Malaria cases in Florida and Texas: Here’s what you need to know

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Cancer drug shortages should be causing more outrage

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

knowledge

Public health communication lessons from Covid

An outrageous hospital charge: I paid $710 for an hour of babysitting

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Sage considers ways to reduce costs following FDA rejection

Pennsylvania man bitten on the head by bear during attack in his garage

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

explore

explore

Wikipedia

Wikipedia